Network-Targeted Neuromodulation for Nicotine Dependence in Schizophrenia

Clinical trial NCT06389266 · COMPLETED

Trial details

NCT number: NCT06389266
Sponsor: Vanderbilt University Medical Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Schizophrenia Nicotine Dependence

Start date: 2023-06-15
Primary completion: 2025-09-15
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.